Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Clin Microbiol 2013 Aug;51(8):2758-60
Date
06/14/2013Pubmed ID
23761153Pubmed Central ID
PMC3719601DOI
10.1128/JCM.00979-13Scopus ID
2-s2.0-84880637996 (requires institutional sign-in at Scopus site) 14 CitationsAbstract
A chromogenic medium for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, VRESelect, was compared to bile esculin azide agar with 6 μg/ml vancomycin (BEAV) for the isolation of vancomycin-resistant enterococci (VRE) from stool specimens. At 24 to 28 h, VRESelect demonstrated 98.7% (confidence interval [CI], 96.1 to 99.7%) sensitivity and 99.0% (CI, 98.0 to 99.6%) specificity versus 85.1% (CI, 79.8 to 89.5%) and 90.1% (CI, 79.8 to 89.5%) sensitivity and specificity, respectively, for BEAV.
Author List
Anderson NW, Buchan BW, Young CL, Newton DW, Brenke C, Lapsley L, Granato PA, Ledeboer NAAuthors
Blake W. Buchan PhD Professor in the Pathology department at Medical College of WisconsinNathan A. Ledeboer PhD Chief, Professor in the Pathology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AgarBacteriological Techniques
Chromogenic Compounds
Culture Media
Enterococcus faecalis
Enterococcus faecium
Feces
Gram-Positive Bacterial Infections
Humans
Prospective Studies
Sensitivity and Specificity
Time Factors
Vancomycin Resistance